跳至主要内容
临床试验/CTRI/2018/03/012681
CTRI/2018/03/012681尚未招募2 期

A Prospective open labelled phase II non randomized clinical trial on mineral drug of Appalakara Chooranam for the treatment of Cegana vatham (Cervical Spondylosis)

Dr R Neelavathy MD Siddha PhD1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2018年3月30日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
40
试验地点
1
主要终点
The therapeutic efficacy of trial drug Appalakara chooranam on Cegana Vatham

研究概览

简要总结

The Study is A prospective open labelled phase II non randomized clinical trial to evaluate the therapeutic efficacy of mineral drug of Appalakara Chooranam for the treatment of Cegana Vatham 30mg kg BW daily twice time per day with water for 30 days in 40 patients during the trial period of 18 months that will be conducted in government siddha medical college and hospital palayamkottai tirunelveli tamilnadu the primary out come will be the therpeutic efficacy of trial drug  Appalakara Chooranam on Cegana Vatham  The Secondary outcome will be the evaluation of siddha diagnostic parameters

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Open Label

入排标准

年龄范围
30.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Neck pain radiating to upper limb with or without numbness giddiness and neck stiffness Restriction neck movement Willing for doing laboratory investigations and x ray imaging The neck disability index score should be equal or greater then 40 present.

排除标准

  • Traumatic injury Systemic hypertension Ischemic heart diseases Chronic kidney disease Tuberculosis in spine Secondary malignancy Chronic systemic illness Congenital spinal anomalies.

结局指标

主要结局

The therapeutic efficacy of trial drug Appalakara chooranam on Cegana Vatham

时间窗: The therapeutic efficacy of trial drug Appalakara chooranam on Cegana Vatham

次要结局

  • Evaluation of Siddha diagnostic parameters(30 days)

研究者

发起方
Dr R Neelavathy MD Siddha PhD
申办方类型
Government medical college

研究点 (1)

Loading locations...

相似试验